All In Biotech

Drug Trial Radar · NCT02984384

PREVENTion of Clot in Orthopaedic Trauma

PREVENTion of Clot in Orthopaedic Trauma (PREVENT CLOT): A Randomized Pragmatic Trial Comparing the Complications and Safety of Blood Clot Prevention Medicines Used in Orthopaedic Trauma Patients

Last checked: Nov 19, 2026Latest source record: May 14, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 12,424 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

12,424

Actual

Start

Apr 24, 2017

Primary completion

Feb 18, 2022

Study completion Feb 18, 2022

Sponsor

Lead sponsor
Major Extremity Trauma Research ConsortiumAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Patient-Centered Outcomes Research Institute
First posted
Dec 6, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare aspirin versus low-molecular weight heparin (LMWH) (Enoxaparin) as a thromboprophylaxis in patients who sustain a fracture.

Conditions

  • Blood Clot
  • Trauma

Interventions

  • Acetylsalicylic acidDrug

    The Aspirin intervention will be 81 mg enteral (by mouth, feeding tube or rectal) twice a day with no variation in dosing allowed.

  • Low Molecular Weight Heparin (LMWH)Drug

    The LMWH intervention will be 30 mg enoxaparin subcutaneous (under the skin) twice a day with variations in dosing allowed, per the standard of care at sites, as needed for patients who are very obese or exhibit renal dysfunction.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With All-cause MortalityTime frame: 90 days

Locations

21 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Arizona

    Tucson, Arizona

  • University of Miami Ryder Trauma Center

    Miami, Florida

  • Methodist Hospital

    Indianapolis, Indiana

  • University of Maryland R Adams Cowley Shock Trauma Center

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire

  • Carolinas Medical Center

    Charlotte, North Carolina

  • Wake Forest University Baptist Medical Center

    Winston-Salem, North Carolina

  • MetroHealth Medical Center

    Cleveland, Ohio

  • Allegheny General Hospital

    Pittsburgh, Pennsylvania

  • Rhode Island Hospital, Brown University

    Providence, Rhode Island

  • University of Tennessee, RegionOne Medical Center

    Memphis, Tennessee

  • Vanderbilt Medical Center

    Nashville, Tennessee

  • University of Texas Health Science Center at Houston

    Houston, Texas

  • San Antonio Military Medical Center

    San Antonio, Texas

  • Inova Fairfax Hospital

    Falls Church, Virginia

  • Harborview Medical Center

    Seattle, Washington

  • University of Wisconsin

    Madison, Wisconsin

  • University of Calgary, Foothills Medical Centre

    Calgary, Alberta, Canada

  • McMaster University, Hamilton General Hospital

    Hamilton, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.